Zhejiang Huahai Pharmaceutical Co., Ltd.SSE: 600521

(600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Conversion Results of Convertible Corporate Bonds and Share Changes

· Issued by Zhejiang Huahai Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600521 · · 5 pages · Chinese

Summary by 6ix AI

Zhejiang Huahai Pharmaceutical Co., Ltd. has announced the results of the conversion of its convertible corporate bonds and the resulting changes in share capital. As of the end of September, a small number of bonds have been converted into shares, while the vast majority remain unconverted. The announcement details the issuance and trading of the bonds, their conversion period, and the adjustments to the conversion price over time. The filing also includes information on the number of shares before and after the conversion, reflecting a slight increase in total shares outstanding.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600521zhejiang-huahai-pharmaceutical-co-ltdannouncement-on-conversion-results-of-convertible-corporate-bonds-and-share-changes

Release

Announcement on Conversion Results of Convertible Corporate Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from Zhejiang Huahai Pharmaceutical

Later from Zhejiang Huahai Pharmaceutical

All Zhejiang Huahai Pharmaceutical news releases